Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment

被引：21

作者：

Arber, C. ^{[1
]}

Buser, A.

Heim, D.

Weisser, M.

Tyndall, A.

Tichelli, A.

Passweg, J.

Gratwohl, A.

机构：

[1] Univ Basel Hosp, Div Hematol, Dept Med, CH-4031 Basel, Switzerland

[2] Univ Basel Hosp, Div Infect Dis, Dept Med, CH-4031 Basel, Switzerland

[3] Univ Basel Hosp, Div Rheumatol, Dept Med, CH-4031 Basel, Switzerland

来源：

BONE MARROW TRANSPLANTATION | 2007年 / 40卷 / 06期

关键词：

D O I：

10.1038/sj.bmt.1705766

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 [生物物理学];

摘要：

引用

页码：597 / 598

页数：2

共 10 条

[1]

Ureaplasma urealyticum arthritis and bacteremia in agammaglobulinemia [J].

Asmar, BI ;

Andresen, J ;

Brown, WJ .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (01) :73-76

[2]

High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma [J].

Buser, AS ;

Heim, D ;

Bucher, C ;

Tichelli, A ;

Gratwohl, A ;

Passweg, JR .

BONE MARROW TRANSPLANTATION, 2004, 33 (10) :1011-1014

[3]

Pharmacokinetics of rituximab and its clinical use: Thought for the best use? [J].

Cartron, Guillaume ;

Blasco, Helene ;

Paintaud, Gilles ;

Watier, Herve ;

Le Guellec, Chantal .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (01) :43-52

[4]

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab [J].

Goldberg, SL ;

Pecora, AL ;

Alter, RS ;

Kroll, MS ;

Rowley, SD ;

Waintraub, SE ;

Imrit, K ;

Preti, RA .

BLOOD, 2002, 99 (04) :1486-1488

[5]

Rituximab for the treatment of diffuse large B-cell lymphomas [J].

Held, Gerhard ;

Poschel, Viola ;

Pfreundschuh, Michael .

EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) :1175-1186

[6]

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma [J].

Horwitz, SM ;

Negrin, RS ;

Blume, KG ;

Breslin, S ;

Stuart, MJ ;

Stockerl-Goldstein, KE ;

Johnston, LJ ;

Wong, RM ;

Shizuru, JA ;

Horning, SJ .

BLOOD, 2004, 103 (03) :777-783

[7]

Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

[8]

Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation [J].

Nishio, Mitsufumi ;

Fujimoto, Katsuya ;

Yamamoto, Satoshi ;

Endo, Tomoyuki ;

Sakai, Toshiya ;

Obara, Masato ;

Kumano, Kohki ;

Yamaguchi, Keisuke ;

Takeda, Yukari ;

Goto, Hideki ;

Sato, Norihiro ;

Koizumi, Kazuki ;

Mukai, Masaya ;

Koike, Takao .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (04) :349-354

[9]

Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma [J].

Shortt, J. ;

Spencer, A. .

BONE MARROW TRANSPLANTATION, 2006, 38 (06) :433-436

[10]

The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma [J].

Van Besien, Koen .

BLOOD REVIEWS, 2006, 20 (05) :235-244

← 1 →